Market Tracker

10/22 6:06pm ET

Transition Therapeutics Inc (NASDAQ:TTHI)

6.34
Data as of 3:59pm ET
 +0.01 / +0.16%
Today’s Change
4.36
Today|||52-Week Range
8.22
+11.42%
Year-to-Date

Today’s Trading

Previous close6.33
Today’s open6.33
Day’s range6.07 - 6.51
Volume28,618
Average volume (3 months)16,276
Market cap$202.6M
Dividend yield--
Data as of 3:59pm ET, 10/22/2014

Growth & Valuation

Earnings growth (last year)-74,855.56%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratio--
Price/Sales--
Price/Book4.03

Competitors

 Today’s
change
Today’s
% change
CALACalithera Bioscience...-0.91-8.64%
DNDNDendreon Corp-0.07-6.36%
VCYTVeracyte Inc+0.12+1.55%
OXFDOxford Immunotec Glo...-0.21-1.42%
Data as of 3:59pm ET, 10/22/2014

Financials

Next reporting dateNovember 11, 2014
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$0.00
Annual profit (last year)-$20.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Tony F. Cruz
Chief Operating Officer
Carl Damiani
Corporate headquarters
Toronto, Ontario

Forecasts